Nilvadipine

尼伐地平

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNilvadipine
Drug Alias Namenilvadipine尼瓦地平nilvadipinonilvadipinumNivadipine +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockers
TargetsVoltage-gated L-type calcium channel
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1989/01/17
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC08CA10
Related LinksWikipediaDrugBankKEGG